Ionpath + press release
WebGenerating Revenue. 1. Early Stage VC (Series A1) $2.6M. $2.6M. 00.00. Completed. Startup. To view Ionpath’s complete valuation and funding history, request access ». Web8 nov. 2024 · MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled …
Ionpath + press release
Did you know?
Web20 aug. 2024 · MENLO PARK, Calif., Aug. 20, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the appointment of Sander Gubbens, PhD, as its new CEO. Dr.... Web13 mei 2024 · The Life Sciences team advised Ionpath, Inc. on its strategic investment by Thermo Fisher Scientific. Ionpath, Inc., based in Menlo Park, California, is a pioneer in …
WebIonpath General Information Description Developer of an ion beam imaging technology designed to offer tissue imaging and analysis to accelerate discovery and improve … Web24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by Samsara...
Web1 jan. 2024 · Ionpath® is a registered trademark and MIBI™ & MIBIscope™ are trademarks of Ionpath, Inc. For Research Use Only. Not for use in diagnostic procedures. Contact … Web17 jun. 2024 · Press release content from PR Newswire. The AP news staff was not involved in its creation. IONpath appoints Brad Nelson to its leadership team as Senior Vice President of Marketing and Corporate Strategy
Web5 nov. 2024 · MIBIscope allows researchers to visualize over 40 biomarkers simultaneously with high resolution, sensitivity, and throughput, and is compatible with standard tissue processing techniques Menlo Park, Calif. – IONpath, Inc., a company revolutionizing multiplexed tissue imaging, launched the MIBIscope™ System, the first commercially …
je newsWebThe MIBIscope enables over 40 markers to be visualized simultaneously with single step staining and single step imaging. MIBIscope images from a 3mm x 3mm scan of a granulomatous lung section from a Mycoplasm tuberculosis infected patient. The image to the left shows immune infiltrate in the infected tissue (CD45, yellow; CD31, red; SMA, … je news todayWeb20 aug. 2024 · (2024-08-20) IONpath Appoints Sander Gubbens, PhD, as Chief Executive Officer (2024-08-20) IONpath Appoints Sander Gubbens, PhD, as Chief Executive Officer. Stockhouse.com uses cookies on this site. ... We will not release or resell your information to third parties without your permission. jen exomanWebMultiplexed Ion Beam Imaging (MIBI™) technology from Ionpath enables high-definition spatial proteomics that uniquely provides actionable analysis of the tissue microenvironment—delivering novel insights into disease … jenex magrathWeb24 sep. 2024 · Proceeds will be used for the further development and deployment of IONpath’s revolutionary MIBI technology, affirming its leadership in high-definition spatial proteomics MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by … jeney jeney and o\\u0027connorWeb11 mei 2024 · MENLO PARK, Calif.-- (BUSINESS WIRE)-- #oncology --Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher … jene youngWeb20 aug. 2024 · IONpath, Inc., is a pioneer in high-definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve … je new vacancy 2022